Last 15 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Solventum Corporation's quarterly P/E stands at 233.2x, up 856.9% year-over-year — indicating the stock has re-rated higher or earnings have softened.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 8.49 | 233.21 | 53.54 | 2.53 | 37.18 | 24.37 | 91.75 | 24.90 | 25.92 | 12.69 | — | — | — |
| — | +856.9% | -41.6% | -89.8% | +43.4% | +92.0% | — | — | — | — | — | — | — | |
| P/S Ratio | 1.57 | 1.43 | 1.74 | 1.53 | 1.54 | 1.61 | 1.39 | 1.46 | 1.10 | 1.49 | — | — | — |
| — | -11.1% | +25.1% | +4.9% | +39.5% | +7.8% | — | — | — | — | — | — | — | |
| P/B Ratio | 2.62 | 2.31 | 2.75 | 2.57 | 3.65 | 4.07 | 3.90 | 3.80 | 3.20 | 3.12 | — | — | — |
| — | -43.4% | -29.4% | -32.4% | +13.9% | +30.6% | — | — | — | — | — | — | — | |
| P/FCF | — | — | 108.52 | — | 56.30 | — | 31.32 | 39.88 | 7.72 | 8.83 | — | — | — |
| — | — | +246.4% | — | +629.0% | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 6.45 | 18.49 | 2.19 | 15.79 | 15.33 | 18.39 | 16.41 | 11.92 | 11.00 | 9.29 | — | — | — |
| — | +0.6% | -86.6% | +32.4% | +39.4% | +98.0% | — | — | — | — | — | — | — | |
| EV / EBIT | 7.90 | 49.32 | 41.39 | 2.54 | 25.01 | 36.39 | 39.12 | 17.76 | 19.74 | 13.12 | — | — | — |
| — | +35.5% | +5.8% | -85.7% | +26.7% | +177.3% | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Solventum Corporation's operating margin was 4.0% in Q1 2026, down 79.9 pp QoQ and down 3.3 pp YoY. The trailing four-quarter average of 26.1% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 53.5% | 54.7% | 49.3% | 56.2% | 54.4% | 53.8% | 53.9% | 56.0% | 54.6% | 58.1% | 56.9% | 58.3% | 57.3% |
| — | +1.6% | -8.6% | +0.4% | -0.5% | -7.4% | -5.2% | -4.0% | -4.6% | +2.8% | +15.8% | -1.5% | — | |
| Operating Margin | 26.2% | 4.0% | 84.0% | 6.5% | 9.9% | 7.3% | 6.6% | 13.2% | 11.7% | 18.9% | 19.9% | 24.3% | 20.1% |
| — | -45.0% | +1181.4% | -50.5% | -15.5% | -61.1% | -67.1% | -45.6% | -41.6% | +4.1% | +78.6% | +13.0% | — | |
| Net Margin | 18.7% | 0.6% | 3.2% | 60.4% | 4.2% | 6.6% | 1.5% | 5.9% | 4.3% | 11.8% | 13.4% | 22.2% | 15.5% |
| — | -90.2% | +111.1% | +930.8% | -2.6% | -43.7% | -88.8% | -73.6% | -72.3% | -19.3% | +183.3% | +30.2% | — |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 38.9% | 0.3% | 1.3% | 29.3% | 2.6% | 4.4% | 1.0% | 4.0% | 2.6% | 3.1% | 3.6% | 6.1% | 2.7% |
| — | -94.1% | +24.6% | +628.5% | -1.6% | +44.2% | -72.4% | -34.4% | -3.2% | +22.4% | +237.3% | +111.3% | — | |
| ROA | 10.8% | 0.1% | 0.4% | 8.7% | 0.6% | 0.9% | 0.2% | 0.8% | 0.6% | 1.7% | 2.0% | 3.3% | 2.4% |
| — | -90.3% | +109.9% | +947.6% | +0.1% | -42.9% | -89.1% | -75.1% | -74.2% | -23.1% | +184.1% | — | — | |
| ROIC | 16.9% | 0.6% | 14.2% | 1.1% | 1.5% | 1.1% | 1.0% | 2.0% | 1.7% | 1.8% | 2.0% | 3.3% | 2.6% |
| — | -40.6% | +1346.5% | -46.7% | -13.0% | -40.8% | -50.2% | -39.9% | -35.4% | -20.5% | +42.6% | +20.8% | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Solventum Corporation's Debt/EBITDA ratio is 23.5x, up from 2.4x last quarter — elevated, raising questions about debt serviceability. The current ratio has weakened 10.0% YoY to 1.07x, tightening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.00 | 1.02 | 1.00 | 1.03 | 2.14 | 2.43 | 2.71 | 2.54 | 2.90 | 2.16 | 0.71 | 2.56 | 0.01 |
| — | -57.9% | -63.2% | -59.4% | -26.0% | +12.5% | +280.3% | -0.8% | +23015.8% | +28670.5% | — | — | — | |
| Debt / EBITDA | 1.89 | 23.52 | 2.45 | 19.91 | 23.26 | 28.16 | 28.01 | 19.88 | 22.03 | 15.97 | 15.23 | 12.85 | 0.27 |
| — | -16.5% | -91.3% | +0.2% | +5.6% | +76.4% | +83.8% | +54.7% | +8143.2% | +9153.8% | — | — | — | |
| Current Ratio | 1.23 | 1.07 | 1.23 | 1.50 | 1.22 | 1.19 | 1.20 | 1.15 | 1.31 | 1.81 | 1.46 | 1.81 | 1.65 |
| — | -10.0% | +2.4% | +29.9% | -6.4% | -34.3% | -17.5% | -36.0% | -20.9% | +4004.7% | -14.3% | — | — | |
| Quick Ratio | 0.89 | 0.75 | 0.89 | 1.14 | 0.86 | 0.85 | 0.84 | 0.83 | 0.96 | 1.33 | 0.96 | 1.23 | 1.02 |
| — | -12.5% | +5.4% | +38.2% | -10.6% | -35.7% | -12.1% | -32.7% | -5.7% | +2903.7% | -7.1% | — | — | |
| Interest Coverage | 5.94 | 1.31 | 2.14 | 18.01 | 2.00 | 1.37 | 1.12 | 2.56 | 1.84 | 9.44 | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 15 years · Updated daily
Deep dive into SOLV consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SOLV stock.
Solventum Corporation's current P/E is 8.5x. The average P/E over the last 4 quarters is 81.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Solventum Corporation's current operating margin is 26.2%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Solventum Corporation's business trajectory between earnings reports.